Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Lipella Pharmaceuticals Inc. Common Stock
LIPOCurrent price
0.4 USD
-0.031 USD (-7.15%)
Last closed
0.38 USD
Company
–
ISIN
unknown
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
4 154 438 USD
Yield for 12 month
-80.39 %
1Y
3Y
5Y
10Y
15Y
LIPO
Lipella Pharmaceuticals Inc., a biotechnology company, focuses on developing drugs by reformulating the active agents in existing generic drugs and optimizing these reformulations for various applications. The company develops LP-10, a formulation of tacrolimus that has completed Phase 2a clinical trial for patients with radiation-induced hemorrhagic cystitis; LP-310, a formulation of tacrolimus for the treatment of oral lichen planus; and LP-410, an oral liposomal formulation of tacrolimus for the treatment of oral graft-versus-host disease (GVHD). Lipella Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Pittsburgh, Pennsylvania. Address: 7800 Susquehanna St., Pittsburgh, PA, United States, 15208
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
2 USDP/E ratio
–Dividend Yield
–Current Year
+449 617 USD
Last Year
+184 156 USD
Current Quarter
+136 431 000 USD
Last Quarter
+145 880 USD
Current Year
+447 932 USD
Last Year
-2 363 521 USD
Current Quarter
+136 429 629 USD
Last Quarter
+145 808 USD
Key Figures LIPO
1 year
3 years
5 years
10 years
EBITDA
-4 744 268 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-93.77 %
PEG Ratio
–
Return On Equity TTM
-171.56 %
Wall Street Target Price
2 USD
Revenue TTM
507 204 USD
Book Value
0.22 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
27.9 %
Dividend Yield
–
Gross Profit TTM
-2 363 521 USD
Earnings per share
-0.61 USD
Diluted Eps TTM
-0.61 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics LIPO
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History LIPO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation LIPO
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
6.5822
Price Sales TTM
8.1909
Enterprise Value EBITDA
-4.4037
Price Book MRQ
2.3784
Financials LIPO
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators LIPO
For 52 weeks
0.32 USD
2.71 USD
50 Day MA
0.5 USD
Shares Short Prior Month
896 923
200 Day MA
0.76 USD
Short Ratio
0.01
Shares Short
48 774
Short Percent
0.93 %
BeatStart